SCHEMBL6131055

SCHEMBL6131055

O=C1CC(=O)N(c2ccccn2)C(=S)N1c1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
CD274 Q9NZQ7 6/20 0.49
PDCD1 Q15116 5/20 0.49
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
POLB P06746 1/20 0.44
EP300 Q09472 1/20 0.42
KAT2B Q92831 1/20 0.42
CRBN Q96SW2 1/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
ABL1 P00519 1/20 0.41
NTRK1 P04629 1/20 0.41
FYN P06241 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13848408 0.87 MAPT (0.55) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL6131059 0.85 SMN1; SMN2 (0.56) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL9492440 0.80 SMN1; SMN2 (0.46) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL9788869 0.77 SMN1; SMN2 (0.60) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL2340654 0.76 HPGD (0.57) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL8782338 0.76 SMN1; SMN2 (0.50) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL29048963 0.76 CRBN (0.54) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL181606 0.75 GAA (0.54) SMN1; SMN2KDM4EALDH1A1GAAPOLB
SCHEMBL30475434 0.74 SMN1; SMN2 (0.56) SMN1; SMN2CD274PDCD1KDM4EALDH1A1
SCHEMBL30493292 0.74 SMN1; SMN2 (0.56) SMN1; SMN2CD274PDCD1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921591-B2 Luminescent device material, luminescent device using the same, and amine compound FUJI PHOTO FILM CO., LTD. (JP) 2005-07-26 US disclosed
US-20050065351-A1 Luminescent device material, luminescent device using the same, and amine compound FUJI PHOTO FILM CO., LTD. 2005-03-24 US disclosed
US-20040086748-A1 Luminescent device material, luminescent device using the same, and amine compound FUJI PHOTO FILM CO., LTD. 2004-05-06 US disclosed
US-6689491-B1 HIGH EFFICIENCY GREEN TO RED EMISSION UNDER LOW APPLIED VOLTAGE; HIGH COLOR PURITY; HEAT RESISTANCE FUJI PHOTO FILM CO., LTD. (JP) 2004-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065351-A1 Luminescent device material, luminescent device using the same, and amine compound H1-2, SAT1, CHRM2 SMN1; SMN2 1205/4885CD274 2156/4885PDCD1 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.